| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/26/1997 | CN1143963A Tetracyclic derivatives, process of preparation and use |
| 02/26/1997 | CN1143950A Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure |
| 02/26/1997 | CN1143522A Health ointment for copiopia producing technique thereof |
| 02/26/1997 | CN1143503A Medicinal composition for curing eye injury |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605922 Vision disorders; side effect reduction |
| 02/25/1997 | CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives |
| 02/25/1997 | CA2018978C Preparation of imidazole derivatives for treatment of glaucoma |
| 02/25/1997 | CA2018227C Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997005895A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005880A1 Aqueous compositions containing ciprofloxacine, and related use and process |
| 02/20/1997 | WO1997005862A2 Use of basic amino acids and derivatives for lowering ceramide levels |
| 02/20/1997 | WO1996039147A3 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2228620A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 02/20/1997 | CA2213773A1 Imidazopyridine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758313A1 Combinatorial dihydrobenzopyran library |
| 02/19/1997 | EP0758242A1 Composition and method for treatment of cmv infection |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004762A1 Use of adamantane derivatives for treating diseases of the inner ear |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142816A Crystalline, polymorphic form of (S,S,S)-n-(1-|2-carboxy-3-(n2-mesyllysylamino)propyl¨-1-cyclopenlylcarbonyl)tyrosine |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1034016C Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids |
| 02/11/1997 | US5602137 Treating cardiovascular or circulatory disorders |
| 02/11/1997 | US5602136 Cardiovascular and nervous system disorders |
| 02/11/1997 | US5602104 Skin disorders, conjunctive tissue disorders, antitumor agents |
| 02/11/1997 | US5601839 Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/05/1997 | EP0756636A1 Chondroitinases i and ii, methods of preparation, and use thereof |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756487A1 Method for implanting encapsulated cells in a host |
| 02/05/1997 | CN1141800A Eyedrops for treatment of cataract and production technology thereof |
| 02/04/1997 | US5599937 Heteroaromatic quinuclidinenes, their use and preparation |
| 02/04/1997 | US5599837 Treatment for hypertension or glaucoma in eyes |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599535 Administering a non-steroidal antiinflammatory agent preventing cell lose in eye disorders |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997002830A2 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/30/1997 | CA2226420A1 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/29/1997 | EP0755246A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/28/1997 | US5597839 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
| 01/28/1997 | US5597809 Methyl aspartate mediated retinal cell damage |
| 01/23/1997 | WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 01/22/1997 | EP0754693A2 Novel aminophenylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754046A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0687177B1 Use of lamotrigine for treating aids-related neural disorders |
| 01/21/1997 | US5596013 Inhibitors of phosphodiesterase type iv and production of tumor necrosis factor |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5595997 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 01/21/1997 | US5595978 Composition and method for treatment of CMV retinites |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001339A1 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752993A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 01/15/1997 | EP0752847A1 Ophthalmic composition with decreased viscosity |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0478694B1 use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140409A Treatment of normotensive glaucoma with angiotensin II antagonisto |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751766A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |